Ventures Imara 14. august 2020 Imara Announces First Patient Dosed in Ardent Phase 2b Clinical Trial of IMR-687 in Sickle Cell Disease Acacia Pharma 14. august 2020 Acacia Pharma Group PLC – Results of Placing Acacia Pharma 13. august 2020 Acacia Pharma Group PLC – Interim Results for the Six Months ended 30 June 2020 Bonesupport 31. juli 2020 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Enterome 30. juli 2020 Enterome initiates first clinical trial with EO2401 – an innovative microbiome-antigen (‘OncoMimic’) based cancer immunotherapy candidate targeting aggressive brain cancer Acacia Pharma 27. juli 2020 Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® Second API Supplier for BARHEMSYS® Receives FDA Approval Sanifit 20. juli 2020 Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease Acacia Pharma 16. juli 2020 Acacia Pharma Group PLC – Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo Technologies Acacia Pharma 15. juli 2020 Acacia Pharma Group PLC – Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV VarmX 8. juli 2020 VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants Sideinddeling Første side « Første Forrige side ‹‹ Side 1 Side 2 Nuværende side 3 Side 4 Side 5 Side 6 Side 7 Side 8 Side 9 … Næste side ›› Sidste side Sidste »
